Skip to main content
. 2023 Apr 6;10(6):850–864. doi: 10.1002/acn3.51776

Figure 2.

Figure 2

Principal mechanisms where LRRK2 has been implicated in Parkinson's disease and therapeutic targets. ASO, antisense oligonucleotides; CMA, chaperon‐mediated autophagy; M6P, mannose‐6‐phosphate, deputed to transfer of lysosomal enzymes from the Golgi to the lysosome. Created with Biorender.